Skip to main content

Table 2 Duration and dose by route of treatment; ITT population

From: Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial

Parameter (n = 43)
Intravenous anidulafungin Oral voriconazole
Duration, daysa   
  n 43 14
  Mean ± SD 11.0 (± 6.81) 12.6 (± 8.89)
  Median 10.0 10.0
  Range 1.0–37.0 4.0–38.0
Dose, mg/day   
  n 43 14
  Mean ± SD 117.8 (± 24.09) 364.8 (± 72.86)
  Median 110.0 400.0
  Range 102.7–200.0 193.8–400.0
  1. aIncludes only days on which any dose was taken.
  2. Abbreviations used: ITT, intent-to-treat; SD, standard deviation.